OEM News

Philips, Myocardial Solutions Partner on AI-Enabled Cardiac MR Imaging

The partnership’s goal is to improve survival rates and boost quality of life for people undergoing or recovering from cancer treatment.

Photo: Philips.

Philips began a collaboration with Myocardial Solutions, a developer of cardiac imaging technologies.

The partnership’s goal is to improve survival rates and boost quality of life for people undergoing or recovering from cancer treatment in order to close the gap between heart and cancer care.

The duo touts cardio-oncology innovations like Philips’ acquisition sequence Fast-SENC and Myocardial Solutions’ analysis tool MyoStrain. FAST-SENC uses through-plane spatial modulation of magnetization, allowing pixelwise strain measurement inside heart muscle. MyoStrain software then processes and analyzes the data to generate a clinical report.

Combining the technologies provides detection of early heart failure dysfunction across 48 heart segments in two minutes.

Also instrumental in this partnership is Philips’ SmartSpeed integrated with AI-driven Compressed SENSE and Adaptive-CS-Net technologies to accelerate scan times by up to 3x. Philips’ BlueSeal system with helium-free operations will also be leveraged.

“By combining our innovative BlueSeal innovation and SmartSpeed technologies with Myocardial Solutions’ specialized expertise in cardiac care, we aim to redefine the standard of cardiac care, environmental responsibility, and accessibility,” said Ioannis Panagiotelis, Business Leader of MR at Philips.

Earlier this week, Philips revealed that it began an agreement to sell its Emergency Care business to Bridgefield Capital, a U.S.-based investment firm.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters